NEW YORK (GenomeWeb) – Pressure BioSciences will develop a sample preparation method for Parabase Genomics' targeted next-generation sequencing-based neonatal molecular diagnostics platform, the companies said today.

Parabase will incorporate Pressure BioSciences' patented Pressure Cycling Technology (PCT) sample prep platform into its LifeTime NewbornDx service, which evaluates 350 genes involved in genetic disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.